We investigated whether inflammatory biomarkers and stress are involved in the pathophysiology of idiopathic sensorineural hearing loss (ISHL). Study Design: Individual cohort study. Setting: Two tertiary centers. Patients: Forty-three ISHL and 10 non-ISHL patients seen in our ENT departments from 2004 to 2010 within a week from the onset of new symptoms and without steroid administration before visiting our departments. Intervention: Multiple audiologic evaluations, blood tests including leukocyte counts, natural killer cell activity (NKCA), interleukin 6 (IL-6), tumor necrosis factor, high-sensitivity CRP (hCRP), and the General Health Questionnaire were used to evaluate the systemic stress and inflammatory response. Main Outcome Measures: Correlations between biomarkers and ISHL severity and prognosis were evaluated by statistical analysis. Results: In the ISHL patients, a neutrophil count above the reference range was associated with severe hearing loss and poor prognosis, and was accompanied by low NKCA and high IL-6. In the non-ISHL patients, these associations were not present. The abnormal neutrophil count was independent of preexisting vascular diseases. The abnormal counts responded to treatment and decreased into the reference range. Conclusion: Neutrophil counts above the reference range of a facility will be a useful indicator of poor prognosis of ISHL. Synchronism of different types of NF-JB activation pathways could be required to cause severe ISHL. An NKCA decrease, an acute neutrophil count increase, and an IL-6 increase can induce NF-JB activation in the cochlea and cause severe ISHL. Further epidemiologic surveys should be conducted to evaluate whether stressful life events increase the risk of severe ISHL onset. Key Words: Idiopathic sensorineural hearing lossVNatural killer cellVNeutrophilVStress response theory.
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A number of etiologies of idiopathic sudden sensorineural loss (ISHL) have been proposed, including viral infection, vascular disturbance, immune-mediated mechanisms, and membrane breaks. However, there is no conclusive evidence for any particular hypothesis (1Y3). Recently, Merchant et al. (1, 4) and Adams et al. (5) hypothesized that different kinds of systemic stress converge at abnormal activation of a transcriptional factor named NF-JB in the unilateral cochlear lateral wall and cause ISHL. In general, NF-JB plays a pivotal role in immune and inflammatory responses. Adams (6) demonstrated that intraperitoneal injection of lipopolysaccharide endotoxin (LPS) consistently resulted in activation of NF-JB in the lateral wall of the unilateral inner ear. Our past experiments using animals also demonstrated that NF-JB activation in the cochlear lateral wall is a cause of sensorineural hearing loss (7) . In addition, we demonstrated that interleukin 6 (IL-6) upregulation in the lateral wall and tumor necrosis factor (TNF) upregulation in the cochlea tissue induced sensorineural hearing loss (8, 9) ; both cytokines are involved in NF-JBYassociated cellular stress pathways (10Y12).
To evaluate the systemic stress response theory of ISHL, we screened several biomarkers related to systemic stress and cochlear inflammation. First, we analyzed white blood cell counts and natural killer cell activity (NKCA), as they are enhanced and suppressed by systemic stress and have critical roles in the immune system (13, 14) . In addition, white blood cell counts are involved in the pathogenesis, reflect the severity, and predict the prognosis of cardiovascular and cerebrovascular diseases (15Y18). Next, we analyzed the IL-6 and TNF. IL-6, in particular, could have an important role in NF-JBY associated cochlear injuries because there is a positive feedback loop involving IL-6 and NF-JB (10) . Finally, we analyzed high-sensitivity C-reactive protein (hCRP) because higher levels of hCRP and IL-6 are associated with a higher likelihood for small tissue damage such as a cerebral infarction less than 10 mm in diameter (19Y21).
METHODS

Subjects
Diagnosis of ISHL was based on the criteria of the Sudden Deafness Research Committee of the Japanese Ministry of Health, Labor and Welfare (Table 1) . Patients with vertigo were not excluded as in recent reports (22Y24) because there is no internationally verified evidence that the acute sensorineural hearing loss with vertigo results from a specific cause, and it is thus still considered idiopathic.
Other inclusion criteria for this study were as follows: visiting our departments within 1 week (1w) after onset of symptoms, no history of steroid treatment by a previous physician, and no abnormal findings causing hearing loss on a magnetic resonance imaging. HL was defined as an average of pure-tone threshold at 0.25, 0.5, 1, 2, and 4 kHz. Patients with abnormal HL of the contralateral ear were excluded. We calculated the 95 percentile HL of otologically normal population at a given age using International Organization for Standardization 7029. If HL was above the 95 percentile, we defined the HL as abnormal. The past and present medical history was taken in detail, and the patients with current symptoms of infection and with medications modulating the immune system were excluded. Forty-three patients with ISHL (male:female, 23:20; age, 57 T 15 yr) fit within the above conditions.
To compare the biomarker profile, 10 non-ISHL patients (male:female, 2:8; age, 52 T 15 yr) were also included in the present study. They were 4 patients with Ménière's disease, 3 with fluctuating sensorineural hearing loss without vertigo, 2 with suspected perilymph fistula, and 1 with bilateral progressive sensorineural hearing loss. They visited our departments within 1w after onset of the acute change of symptoms, such as acute deterioration of hearing or acute increase of tinnitus loudness. They had no history of steroid treatment by a previous physician after the latest acute change of symptom. Their contralateral HLs were not necessarily within normal limit. Blood samples were taken at the first visit, and then, all ISHL patients were given intravenous administration of corticosteroid, vitamin B 12 and adenosine triphosphate from 7 to 12 days as a standard treatment. The patients were followed for more than 2 months or less than 2 months if hearing loss disappeared completely before that time.
The study was approved by the local ethics committee of both universities, and informed consent was obtained from the patients.
Hearing Level Evaluation
HL was evaluated at the initial visit and at 1w, 3 or 4 w, and 2 months or more afterward. If the patient did not respond to the maximum sound level produced by the audiometer, we defined the threshold as 5 dB more than the maximum level.
Recovery rate (RR) (%) was calculated by dividing the hearing gain by the difference in initial hearing level between the affected and unaffected sides according to previous articles (25, 26) . The formula is as follows: RR (%) = (initial HL of the affected ear Y HL of the affected ear at a time point on the time course) / (initial HL of the affected ear Y HL of the unaffected ear).
Biomarker Examinations
No patients were given any corticosteroids before collecting the first blood samples. If possible, blood samples were taken 2 times at the first visit and 1w or more after completing the standard treatment. By collecting samples before steroid administration and by waiting to collect samples until a week or more after completion of steroid treatment, we excluded confounding factors of biomarkers from steroid administration like wide fluctuation of neutrophil counts and differences in patients' acute responses to steroid at the 2 time points. The following variables were measured and analyzed: neutrophil, lymphocyte, and monocyte counts, NKCA, IL-6, TNF, and hCRP. NKCA was measured with 51 Cr-releasing assay. IL-6 was measured with chemiluminescent enzyme immunoassay. TNF was measured with enzyme-linked immunosorbent assay.
These measurements were performed by SRL, Inc. (Tokyo, Japan), except for the leukocyte counts, which were analyzed by the on-site clinical laboratories of each university. All measurements were made by the same laboratory for each patient during the measurement time course. Neutrophil counts, NKCA, and IL-6 of ISHL patients were taken in 38, 40, and 43 patients at the first visit, respectively. The sample numbers of other variables were shown in Table 2 . A neutrophil count was taken multiple times after the first visit in 19 patients.
It is known that baseline neutrophil counts are relatively stable in individuals but have a considerable normal range in healthy humans (27) . Consistent with this knowledge, reference ranges of the neutrophil count at Keio University Hospital and Iwate University Hospital are 1,400 to 5,950 and 1,610 to 5,950/Kl, respectively, and the ranges are the same for male and female subjects. Therefore, the upper limit of the normal neutrophil count was defined as 5,950/Kl. For NKCA, IL-6, and TNF, reference ranges of Japanese population were not determined.
General Health Questionnaire
Subjective physical and psychological statuses of 21 patients were assessed via the Japanese version of the 28-item General Health Questionnaire (GHQ) (28, 29) ; the Likert method was used to score the GHQ values, including somatic symptoms, anxiety and insomnia, social dysfunction, and depression subscales (30) . The maximum score is 28, and a healthy person should have a score of less than 5.
Data Analysis
To analyze the strength of the relationships between HL, RR, and biomarkers, we conducted Pearson's or Spearman's correlation analysis. The latter method was used to analyze correlations between hCRP and variables because the standard deviation of the values was high and not appropriate for Pearson's analysis. Although the correlation analysis is useful for showing linear association between variables, associations between clinical symptoms and biomarkers are not necessarily linear. Therefore, the associations were also evaluated by categorizing patients into biomarker quartiles. In addition, the differential counts of leukocytes are well-documented standardized markers of inflammation in every clinical laboratory in the world. Therefore, the patients were classified into 2 groups: either outside of or within the reference range of the neutrophil count. To evaluate the differences of the means of the biomarkers between 3 or more patient groups, analysis of variance (ANOVA) followed by Tukey's multiple comparison test was used. To evaluate the differences and changes of variables between the 2 groups, the t test, Mann-Whitney U test, or the paired t test were used as shown in the legend. p G 0.05 was considered significant.
RESULTS
Variables of ISHL and non-ISHL evaluated in the first visit are summarized in Table 2 . There was no statistical difference in the variables between the 2 patient groups, except for monocyte counts. Five of 38 ISHL patients showed neutrophil counts above the reference range, whereas no non-ISHL patients showed counts above the range. No patients showed counts below the range in either group.
Correlations between variables are summarized in Table 3 . The correlation between RR 1w after starting treatment (1w RR) and RR at the final time point (final RR) showed strong statistical significance in ISHL patients (r = 0.87, p = 5 Â 10 j12 ). The neutrophil count at the first visit (Neut) was correlated with HL at the first visit, the 1w RR, and the final RR (r = j0.64, j0.63, and j0.63; p = 0.00001, 0.00003, and 0.00002, respectively). It was also correlated with NKCA and IL-6 (r = j0.46 and 0.44; p = 0.005 and 0.005, respectively). The total values of 4 subscales of GHQ did not show correlation with any variable. TNF was not significantly correlated with HL, the 1w RR, and the final RR.
In non-ISHL patients, biomarkers were not correlated with other variables.
Consistent with the correlation analysis, the uppermost quartile of the neutrophil counts (the fourth quartile, 4Q in Fig. 1 , Q4963/Kl) showed significantly higher HL (A) and worse final RR (B) than the lower 2 quartiles (the first and the second quartiles, 1Q and 2Q, G3912/Kl) (p G 0.001). The second uppermost quartile (the third quartile, 3Q, 3912-4963/Kl) also showed significantly higher HL and the final RR than the first quartile (1Q, G2890/Kl) and the lower two quartiles (p G 0.05), respectively. In addition, there was no difference of neutrophil counts between patients with and without past or present histories of vascular diseases (e.g., hypertension, coronary artery disease, stroke, diabetes, hyperlipidemia) (p = 0.44; Fig. 1C ).
FIG. 1.
The relationship between neutrophil quartile at the first visit, hearing level at the first visit (HL), and the final recovery rate (RR). The patients were classified according to the quartile of neutrophil counts: the first quartile (1Q, G2890/Kl), the second (2Q, 2890Y3912/Kl), the third (3Q, 3912Y4963/Kl), and the fourth (4Q, 94963/Kl). The 4Q patients showed worse HL (A) and the final RR (B) than patients of lower 2 quartiles. Patients in 3Q showed worse HL and the final RR than those in 1Q and 2Q, respectively. The neutrophil count did not show a significant difference between patients with and without vascular diseases (C). The change of neutrophil counts was observed at the first visit (first) and 1w or more after completion of steroid administration (second) (D). The counts of 4Q significantly changed from above the reference range to within the range. The change of 1Q was also significant, but the values were within the reference range at both time points. ** and * indicate p G 0.01 and p G 0.05, respectively, with ANOVA followed by Tukey's test.
We also analyzed the counts of 19 patients at the following time points: at the first visit without steroid treatment (Fig. 1D, 1st ) and 1w or more after completion of treatment (2nd). The counts of patients in 1Q and 4Q showed significant change during the time course (p G 0.05). The average counts of 4Q changed from above the reference range into the normal range.
When the patients were classified into 2 groups, either above the reference range of the neutrophil count (Fig. 2,  abnormal) or within the range (normal), patients with abnormal counts showed worse HL (A), 1w RR (B), and final RR (C) than others (p G 0.01 for each; Fig. 2 ). All the ISHL patients with abnormal counts had vertigo, whereas it was present in 29% of others (Fig. 2D , p G 0.01). On the other hand, all of the patients with Ménière's disease had vertigo, although their counts were normal (3730/Kl T 963).
The patients with abnormal neutrophil counts showed significantly lower NKCA (20%) than others (33%) (p G 0.05; Fig. 3 ). The average of the GHQ scores was above the normal limit (Table 2 ). However, it did not show a significant correlation with severity, prognosis of ISHL, and biomarkers.
The patients with abnormal neutrophil counts showed significantly higher IL-6 (2.36 T 0.83 pg/ml) at the first visit than in patients with normal counts (1.1 T 0.60 pg/ml) (p G 0.005; Fig. 4) .
TNF did not show a significant association with the severity and prognosis of ISHL and other biomarkers.
The standard deviation of hCRP was very high (Table 2) . It showed a correlation with HL at the first visit (Table 3) . However, hCRP did not show statistical significance with HL when the patients were classified into 4 groups according to the hCRP quartiles (Fig. 5) .
DISCUSSION
Correlation analysis suggests that neutrophil counts might be a clinically meaningful indicator for predicting severity and prognosis, and might be involved in the pathogenesis of ISHL. Consistent with this speculation, the neutrophil count quartiles showed significant association with those variables, and the upper most quartile decreased from above the reference range to within it during the time course. Furthermore, we demonstrated that patients with lower NKCA, abnormally high neutrophil count, and higher IL-6 showed severe hearing loss and poor prognosis as compared with those with normal neutrophil counts. These correlations were lost in the non-ISHL patients. These results suggest that these biomarkers may be specifically involved in the pathogenesis of ISHL. Sugiura et al. (31) demonstrated that an ISHL-affected ear has a high concentration of proteins in the inner ear fluid space using fluid-attenuated inversion recovery MRI. However, the signal is scant and does not diffuse into the fluid space outside the inner ear. It seems that the inflammatory biomarkers from the inner ear are too sparse to affect the inflammatory response of the whole body or to change the circulating biomarkers. It is more likely that systemic biomarkers changed before the ISHL onset rather than the after it. In addition, although the patients in the fourth neutrophil quartile had significantly worse recovery and had been experiencing hearing loss, the counts decreased during the time course of measurement. Therefore, it seems unlikely that the count of 4Q at the first visit would be the result of the psychological stress of hearing loss. However, we could not completely exclude the possibility that biomarkers changed after the onset of ISHL.
Decreased NKCA and Elevated Neutrophils May Reflect the Systemic Stress of Severe ISHL Patients
The natural killer cell has critical roles in resistance against both viral and bacterial infections by enhancing the response of the neutrophil, shaping the immune response after infection, and regulating immune responses to autoantigens (32Y36). However, NKCA is reduced by fatigue, stressful life events, inability to cope with stress, and short sleep duration (37Y41). Notably, all have been suggested to be causes of ISHL (42Y44). Kanzaki (45) suggested the association of depletion of NKCA followed by systemic stress with the onset of ISHL. The decrease of NKCA observed in the present study might also be induced by systemic stress in ISHL patients, although GHQ scores did not have a significant correlation with biomarkers. The decreased NKCA could result in systemic subclinical infection or dysregulation of the immune system and, thus, cause increased neutrophils. Mattox and Simmons (46) also suggested that subclinical infectious disease is associated with the onset and prognosis of ISHL based on the elevated erythrocyte sedimentation rate in ISHL patients. Considering these findings, the decreased NKCA and the abnormally high neutrophil count might result from psychological and physical stress in ISHL patients.
Elevated Neutrophils and IL-6 Induced by Systemic
Stress Can Activate NF-JB in the Cochlear Lateral Wall IL-6 was higher in patients with abnormal neutrophil counts than in patients with normal counts. It is reported that neutrophil counts and IL-6 are involved in subclinical disease, injury, and repair of the nervous system, heart, and other organs as well as cochlear injury (8,21,47Y50 ). IL-6 induces neutrophilia, and neutrophil-derived IL-6 results in high IL-6 (49, 51, 52) . This interaction between IL-6 and neutrophil could induce higher IL-6 in patients with abnormal neutrophil counts than in patients with normal counts.
Elevated IL-6 may induce the abnormal NF-JB activation in the cochlear lateral wall through a positive feedback loop of the NF-JB stress response system because IL-6 is not only a transcriptional target of NF-JB but also an activator of NF-JB (10, 12) . Local and circulating IL-6 can influence cochlear injuries via classic and trans-signaling, respectively. In trans-signaling, a complex of circulating IL-6 bound to the IL-6 receptor, which occurs naturally or by cleavage from apoptotic neutrophil, can control inflammatory response through binding with gp130, which are displayed by all cells (53) .
FIG. 5.
There was no significant difference of HL between quartiles of hCRP with ANOVA followed by Tukey's test.
We previously observed gp130 expression in the lateral wall as well as NF-JB activation, thus supporting lateral wall NF-JB activation via trans-signaling (7, 9) .
Haubner et al. (54) demonstrated that IL-6 concentration was not significantly different between 48 ISHL patients of various levels of HL and 35 control subjects, although no distinction were made between mild and severe ISHL. In the report, the IL-6 concentration not only from severe ISHL patients but also milder patients might counterbalance the increase of IL-6 in severe ISHL patients. Our findings suggest that the elevated IL-6 may be involved in the onset of severe ISHL but not in milder ISHL pathophysiology because it is accompanied by abnormal neutrophil counts in severe patients.
Elevated Neutrophils May Directly Induce the Stress
Response in the Cochlea An increase of neutrophil counts might activate the stress response in the cochlear lateral wall independent of IL-6 production. The acute or subacute change of the neutrophil counts must be associated with ISHL onset because it was not associated with chronic vascular diseases. Neutrophils have a thrombogenic profile (21) and are correlated with the risk and prognosis of myocardial infarction and stroke (17, 18, 21) . Considering that the ISHL onset mode is like that of infarction of the heart and brain, the thrombogenic profile of the neutrophil may be involved, at least, in the onset of severe ISHL.
The Systemic Stress Response Theory of Severe ISHL
We suggest that an NKCA decrease, acute neutrophil increase, and an IL-6 increase may represent systemic stress in ISHL patients, and these biomarkers can be involved in NF-JB activation in the cochlear lateral wall. Kanzaki et al. (55) also hypothesized that cochlear lateral wall NF-JB activation followed by cytokine production might be a cause of hearing deterioration during maintenance therapy of steroid-dependent sudden sensorineural hearing loss. Based on the present findings, we advocate the stress response theory of severe ISHL as shown in Figure 6 .
Merchant et al. (1) and Adams (6) demonstrated that systemic stress by intraperitoneal injection of LPS caused lateral wall NF-JB activation unilaterally but not bilaterally, and local (i.e., intratympanic) administration of LPS did not activate NF-JB in the lateral wall, in contrast to systemic administration. Physical and psychological stress induce and enhance the inflammatory response including NF-JB activation and IL-6 production (40,56Y59). Furthermore, systemic stress activates the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system, and induces noradrenalin-dependent NF-JB activation and IL-6 production (58, 60) . This activation pathway can occur in the cochlear lateral wall and result in ISHL because there are several kinds of adrenergic receptors in the lateral wall (61Y64). Therefore, systemic stress must enhance the lateral wall stress response more than local stress alone. It remains unknown why systemic stress induces asymmetric hearing loss. There are presumably some predisposing factor(s) in the inner ear. For example, asymmetry of preexisting subclinical minor damage in the inner ear or asymmetry of terminal vascular structure (e.g., stenotic or not stenotic, straight or tortuous) may be the potential explanation for the asymmetric inner ear response against stimulation that activates NF-JB.
Clinical Relevance of Normal Neutrophil Counts
to ISHL Patients in the third neutrophil quartile showed statistically worse HL and prognosis than those in the first quartile, although their neutrophil counts were within the reference range and did not change significantly over the time course. Von Vietinghoff and Ley (27) reported that higher baseline counts, even within the normal range, have been shown to be an independent risk factor for cardiovascular and cancer mortality in meta-analyses and in the National Health and Nutrition Examination Survey study, respectively. Although it remains unclear what the role of the elevated numbers of circulating neutrophils is, patients with increased neutrophil counts may have a higher incidence of more severe ISHL. A large-scale survey should be performed to evaluate this relationship.
TNF and hCRP Does Not Reflect Inner Ear Injury
From ISHL Circulating TNF was not associated with affected HL and prognosis. Um et al. (65) reported the association of TNF polymorphisms with the ISHL pathogenesis. Van Wijk et al. (66) showed that intratympanic TNF inhibitor administration could improve autoimmune inner ear disease. On the other hand, Suslu et al. (67) do not recommend the use of TNF inhibitors in ISHL because of the lower TNF titers documented in 30 ISHL patients compared with 30 healthy patients, which had no response to steroid treatment. In the present study, we also could not support this treatment.
The standard deviation of hCRP was very high, and the quartiles did not show a significant association with HL. Therefore, it does not seem to be a useful biomarker for ISHL patients.
CONCLUSION
Neutrophil counts above the reference range of a facility will be a useful indicator for poor prognosis of ISHL. A systemic stress response starting from an NKCA decrease may be the pathogenesis of severe ISHL. Synchronism of different types of NF-JB activation pathways could be required to cause severe ISHL. Different kinds of pathogenesis may be involved in ISHL, and there are various degrees of severity in ISHL patients. At the present time, it is impossible to directly evaluate cellular responses in the human inner ear. However, further studies on evaluating systemic stress and inflammatory biomarkers in ISHL patients will help to prevent disease and develop new treatments for ISHL patients. In particular, an epidemiologic survey would be important for people who have experienced stressful life events.
